Relay Therapeutics, Inc. is a clinical-stage precision medicine company headquartered in Cambridge, Massachusetts, dedicated to revolutionizing drug discovery and development through its proprietary protein motion platform. The company emphasizes targeting allosteric sites to create innovative therapeutics for patients with distinct genetic mutations, particularly within oncology and other high-unmet need disease areas. With a promising pipeline bolstered by strategic partnerships, Relay Therapeutics is committed to enhancing treatment precision and delivering improved outcomes for patients, thereby driving the future of personalized medicine.